Warburg Pincus leads Series C round for Insilico Medicine

Insilico Medicine, a developer of artificial intelligence systems, has secured $255 million in Series C financing.

22 June 2021•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles